Committee for Advanced Therapies
E23508
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
Statements (43)
| Predicate | Object |
|---|---|
| instanceOf |
committee of the European Medicines Agency
→
regulatory body → scientific committee → |
| abbreviation |
CAT
→
|
| composition |
experts in cell therapy
→
experts in gene therapy → experts in tissue engineering → healthcare professional representatives → patient representatives → |
| country |
European Union
→
|
| field |
advanced therapy medicinal products
→
medicine → pharmacology → regulatory science → |
| goal |
ensure that advanced therapy medicinal products are safe, effective and of high quality
→
facilitate patient access to innovative advanced therapies in the EU → |
| jurisdiction |
European Union
→
|
| language |
English
→
|
| legalBasis |
Regulation (EC) No 1394/2007
→
|
| location |
Amsterdam
→
Netherlands → |
| parentOrganization |
European Medicines Agency
→
|
| partOf |
European Medicines Agency
→
|
| productTypeEvaluated |
combined advanced therapy medicinal products
→
gene therapy medicinal products → somatic cell therapy medicinal products → tissue engineered products → |
| regionServed |
European Economic Area
→
|
| regulatoryScope |
classification of advanced therapy medicinal products
→
evaluation of marketing authorisation applications for advanced therapies → follow-up of authorised advanced therapy medicinal products → scientific advice on advanced therapy development → |
| role |
advise other EMA committees on advanced therapies
→
contribute to development of guidelines for advanced therapies → evaluate advanced therapy medicinal products → provide scientific opinions on advanced therapy medicinal products → support innovation in advanced therapies while ensuring patient safety → |
| sector |
pharmaceutical regulation
→
public health → |
| supervisingBody |
Management Board of the European Medicines Agency
→
|
| website |
https://www.ema.europa.eu/en/committees/committee-advanced-therapies-cat
→
|
| worksWith |
Committee for Medicinal Products for Human Use
→
Pharmacovigilance Risk Assessment Committee → |
Referenced by (3)
| Subject (surface form when different) | Predicate |
|---|---|
|
European Medicines Agency
→
European Medicines Agency → |
hasCommittee |
|
Committee for Advanced Therapies
("https://www.ema.europa.eu/en/committees/committee-advanced-therapies-cat")
→
|
website |